Third quarter: Outlook for 2017 confirmed

• Group sales in the third quarter at year-earlier level (+0.1%)
• Robust organic sales growth across all regions amid negative exchange rate effects
• Healthcare investments and business performance of Liquid Crystals impact EBITDA pre exceptionals (-8.3%)
• Integration of Sigma-Aldrich on track
• Net financial debt lowered by € 1.0 billion to € 10.5 billion
• We confirm the outlook for sales and EBITDA pre for 2017
  

“We generated healthy organic growth in Healthcare and Life Science. In Performance Materials, our diversified portfolio comprising four strong pillars is helping us cope with the challenges in Liquid Crystals. We confirm the full-year guidance despite currency headwinds. Since the beginning of the year, we have reduced our net financial debt by € 1 billion.”

(Stefan Oschmann, CEO and Chairman of the Executive Board)

Audio Calls

• Conference call for journalists
• Conference call for analysts

Downloads

• Quarterly Report Q3/2017 (PDF)
• Media presentation (PDF)
• Related News
• Earnings presentation (PDF)
• Summary (PDF)
• Financial Statement (XLS)
  
• Regional Sector Sales (XLS)
• Press Kit for Journalists (ZIP File)

Social Media

• twitter.com/hashtag/EMD2017Q3